Clinical trial Recruiting at 2 sites Interventional Ages 24 Weeks to 30 Weeks

Comparing non-pharmacological and analgesic approaches for surfactant treatment in premature infants

Official title: NON-pharmacological Approach Less Invasive Surfactant Administration (NONA-LISA) Trial: Protocol for a Randomised Controlled Trial

Run by Copenhagen University Hospital, Rigshospitalet · NCT05609877 · Data updated 2026-11-12

This study is testing if using a non-drug approach during surfactant treatment helps premature infants breathe better compared to using pain relief medication.

More Respiratory Distress Syndrome in Premature Infant trials

Quick facts

Study typeInterventional
Ages24 Weeks to 30 Weeks
SexAll
Enrollment324 (estimated)
SponsorCopenhagen University Hospital, Rigshospitalet
Academic / other
Locations4 sites (Aalborg and 3 other locations)
StatusRecruiting
StartedJune 1, 2024
Main results expectedMay 31, 2028
Study endsMay 31, 2029
Registry record updatedSeptember 20, 2024
Trial IDNCT05609877 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are premature infants born at 24+0 to 29+6 weeks of gestation who require surfactant treatment for respiratory distress syndrome.

Probably not a fit

Patients who have major congenital anomalies or have been intubated prior to randomization will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The NONA-LISA trial is a multicentre, pragmatic, parallel-group, blinded randomized controlled trial conducted at four university hospitals in Denmark. It aims to compare the effectiveness of Less Invasive Surfactant Administration (LISA) using a non-pharmacological approach versus LISA combined with routine analgesic treatment in premature infants born between 24 and 29 weeks of gestation. A total of 324 infants will be enrolled over 36 months, with the primary outcome being the rate of LISA failure, defined as the need for positive pressure ventilation within 24 hours after the procedure. The study seeks to determine if avoiding pre-procedure analgesia can improve outcomes for these vulnerable infants.

Why it matters

Potential benefit: If successful, this study could improve the respiratory outcomes of premature infants by optimizing surfactant administration techniques.

How similar studies have gone: Other studies have shown promise in optimizing surfactant administration techniques, but this specific approach is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Infants born at one of the trial sites with a gestational age of 24+0 to 29+6 weeks and meeting the criteria for first-choice surfactant treatment by LISA as described by Sweet et al.: worsening babies with RDS and FiO2 \> 0.30 on CPAP pressure ≥6 cm H2O.

Exclusion Criteria:

1. suspicion of lung hypoplasia,
2. endotracheal intubation at any time before randomisation,
3. suspicion of pneumothorax, pulmonary haemorrhage or pleural effusion before LISA,
4. major congenital anatomical anomalies as described by the European Surveillance of Congenital Anomalies (EUROCAT).

Where it's running

  • Department of Paediatrics (Intensive Care Neonatology) and Perinatal Research Unit
    Aarhus, Denmark
    Recruiting
  • Department of Neonatal and Pediatric Intensive Care, Blegdamsvej 9
    Copenhagen, Denmark
    Recruiting
  • Neonatalafsnittet, Børn- og Ungeafdelingen, Reberbansgade 15
    Aalborg, Denmark
    Withdrawn
  • H.C. Andersen Børne- og Ungehospital, Kløvervænget 23C, Indgang 60
    Odense, Denmark
    Not yet recruiting

Study contacts

  • Principal investigator: Niklas Breindahl, MD — Copenhagen University Hospital, Rigshospitalet
  • Study coordinator: Lise Aunsholt, MD, PhD
  • Email: lise.aunsholt@regionh.dk
  • Phone: +4561991137

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.